You raise many good points "in hindsight" which is fantastic if you chose to live that way.... The 2 rounds of mice trials have no doubt given them the confidence to put BIT225 forward, enlighten us to how long these specific COVID animal testings have been around? Expecting Biotron to throw their golden child treatment in the ring for expensive COVID trials and to jeopardise HIV without solid foundations for success is not understanding the complexities of biotech. Also during the peak of COVID it would not have been prudent to be running further expensive HIV trials. Yes management have been slow & lacking on partner front, with many questions no doubt... but prudent at the same time while dealing with the headwinds of COVID and limited resources. I am interested in the present situation and the general "timelines" that are given are all they can do without a crystal ball.
- Forums
- ASX - By Stock
- BIT
- Ann: Quarterly Activities Report
Ann: Quarterly Activities Report, page-19
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $19.85M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $23.85K | 1.129M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 155000 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 983781 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 155000 | 0.020 |
12 | 2598963 | 0.019 |
10 | 1719636 | 0.018 |
7 | 2103408 | 0.017 |
13 | 1691225 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 983781 | 4 |
0.023 | 1449422 | 4 |
0.024 | 112849 | 1 |
0.025 | 173000 | 2 |
0.027 | 169508 | 3 |
Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online